{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:10:47Z","timestamp":1790763047709,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T00:00:00Z","timestamp":1653782400000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.therap.2020.07.002","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T11:22:54Z","timestamp":1594380174000},"page":"239-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-9554","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Araujo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Hurault-Delarue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Sommet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Damase-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Benevent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2020.07.002_bib0100","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0140-6736(00)03209-8","article-title":"Prescription of drugs during pregnancy in France","volume":"356","author":"Lacroix","year":"2000","journal-title":"The Lancet"},{"key":"10.1016\/j.therap.2020.07.002_bib0105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.gyobfe.2011.07.044","article-title":"Drugs in pregnancy: study in the EFEMERIS database (2004 to 2008)","volume":"39","author":"Hurault-Delarue","year":"2011","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.therap.2020.07.002_bib0110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/pds.4265","article-title":"Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample","volume":"26","author":"Demailly","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2020.07.002_bib0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","article-title":"French national health insurance information system and the permanent beneficiaries sample","volume":"58","author":"Tuppin","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.therap.2020.07.002_bib0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","article-title":"French health insurance databases: what interest for medical research?","volume":"36","author":"Moulis","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.therap.2020.07.002_bib0125","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2020.07.002_bib0130","unstructured":"ANSM. Exposition \u00e0 l\u2019acide valpro\u00efque et ses d\u00e9riv\u00e9s au cours de la grossesse en France de 2007 \u00e0 2014\u00a0: une \u00e9tude observationnelle sur les donn\u00e9es du SNIIRAM 2016. https:\/\/www.ansm.sante.fr\/Dossiers\/Valproate-et-derives\/Valproate-et-derives\/(offset)\/0 [accessed April 2, 2019]."},{"key":"10.1016\/j.therap.2020.07.002_bib0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jgyn.2013.09.004","article-title":"Qualit\u00e9 des donn\u00e9es p\u00e9rinatales issues du PMSI\u00a0: comparaison avec l\u2019\u00e9tat civil et l\u2019enqu\u00eate nationale p\u00e9rinatale 2010","volume":"43","author":"Quantin","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.therap.2020.07.002_bib0140","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/pds.4556","article-title":"Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: an application to antiepileptic drug use in 4.9 million pregnant women in France","volume":"27","author":"Bloti\u00e8re","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2020.07.002_bib0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.therap.2018.11.014","article-title":"Pharmacoepidemiology in pregnancy","volume":"74","author":"Benevent","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2020.07.002_bib0150","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/pds.2184","article-title":"Prescription drug use during pregnancy in developed countries: a systematic review","volume":"20","author":"Daw","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2020.07.002_bib0155","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00228-008-0546-y","article-title":"Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy","volume":"64","author":"Gagne","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2020.07.002_bib0160","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00228-004-0817-1","article-title":"Drug prescription in pregnancy: analysis of a large statutory sickness fund population","volume":"60","author":"Egen-Lappe","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2020.07.002_bib0165","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.3390\/nu5114760","article-title":"Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects","volume":"5","author":"Czeizel","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.therap.2020.07.002_bib0170","first-page":"142","article-title":"Paracetamol\/Acetaminophen during pregnancy induces prenatal ductus arteriosus closure","author":"Becquet","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.therap.2020.07.002_bib0175","first-page":"2009","article-title":"Paracetamol use during pregnancy and attention and executive function in offspring at age 5 years","volume":"45","author":"Liew","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.therap.2020.07.002_bib0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/archdischild-2012-303043","article-title":"Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis","volume":"100","author":"Cheelo","year":"2015","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.therap.2020.07.002_bib0185","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0895-4356(96)00203-X","article-title":"Use of psychotropic drugs and pregnancy outcome","volume":"49","author":"Larivaara","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.therap.2020.07.002_bib0190","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00315304","article-title":"Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Collaborative Group on Drug Use in Pregnancy (CGDUP)","volume":"45","author":"Marchetti","year":"1993","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595720301220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595720301220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:53:57Z","timestamp":1758567237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595720301220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0040595720301220"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2020.07.002","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2020.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}